Search

Diabetes and hearing loss: a review

As hearing health professionals we often ask, especially in older patients, if they have diabetes; but what is the link? How is it manifested and should it change current practice? Alec Lapira reviews the changing evidence. Early attempts to establish...

Direct-to-consumer hearing devices: a need to combine cosmetic appeal with device capabilities

How safe and desirable are direct-to-consumer amplification devices? A team has put a range of devices through their paces and compared them to a standard NHS hearing device. Why do most individuals who would benefit from hearing aids not try...

Genomic testing for deafness and its implications

Gene therapies for hearing loss are rapidly advancing and will be transitioning to clinical practice. Here, the authors explain why clinicians involved in managing these disorders need to be aware of these advances. Genomic testing in England was significantly reconfigured...

Making audiology work during COVID-19 and beyond

‘New normal’ is another phrase that has become synonymous with this pandemic. In this article, consideration for ‘low-touch’ and ‘no touch’ audiological pathways are described for adoption as the ‘new normal’ for hearing healthcare. The COVID-19 crisis has ushered in...

Migraine related vertigo

Migraine is one of the commonest conditions an otologist will have to manage with up to half of migraineurs displaying vestibular symptoms. David Selvadurai provides an overview and management plan for this increasingly well recognised disorder. Migraine is a common...

Unanswered questions in adult ototoxicity associated with platinum-based chemotherapy

Do the potential side-effects on hearing and tinnitus need to be a ‘necessary evil’ of platinum-based chemotherapy? How strong is our evidence base when offering advice to patients and fellow clinicians? David Baguley and his team from the University of...

The integration of targeted therapy and surgery in advanced thyroid cancer clinical trials

One of the headline speakers, Mark Zafereo, will be talking at IFOS about thyroid cancer. We hear from his team about some of the areas they will be discussing. Locally advanced thyroid cancer generally refers to patients who have significant...

Genetic research on hereditary hearing loss and clinical application in the Chinese population

Congenital deafness in China affects more people than the entire population of Australia. Prof Wang give us a comprehensive insight into one of the main congenital disabilities in China, looking into the causes of deafness and the benefits of genetic...

Temporal bone trauma

Introduction Temporal bone injuries represent one of the more complex management problems presenting to the otolaryngologist. This is largely due to difficulties in assessment and the frequent delays in referral, often as a result of other injuries demanding more immediate...

Congenital CMV: investigations and management in the audiology setting

Congenital cytomegalovirus (cCMV) is the only cause of congenital sensorineural hearing loss (SNHL) for which there is a medical treatment available to prevent further hearing loss. Dr Simone Walter discusses cCMV infection, cCMV-related hearing loss, and how to facilitate their...